TTY Biopharm Co Ltd - ESG Rating & Company Profile powered by AI
The report of TTY Biopharm Co Ltd was assembled by All Street Sevva using cutting edge Cognitive Robots. Scroll down to the end of this page for potential risks for TTY Biopharm Co Ltd based on industry, location and marketcap. This report of TTY Biopharm Co Ltd incorporates intelligence from across the internet as well as from public disclosures by TTY Biopharm Co Ltd.
TTY Biopharm Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | TTY Biopharm Co Ltd | 8.0 | High |
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does TTY Biopharm Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does TTY Biopharm Co Ltd disclose current and historical energy intensity?
Does TTY Biopharm Co Ltd report the average age of the workforce?
Does TTY Biopharm Co Ltd reference operational or capital allocation in relation to climate change?
Does TTY Biopharm Co Ltd disclose its ethnicity pay gap?
Does TTY Biopharm Co Ltd disclose cybersecurity risks?
Does TTY Biopharm Co Ltd offer flexible work?
Does TTY Biopharm Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does TTY Biopharm Co Ltd disclose the number of employees in R&D functions?
Does TTY Biopharm Co Ltd conduct supply chain audits?
Does TTY Biopharm Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does TTY Biopharm Co Ltd conduct 360 degree staff reviews?
Does TTY Biopharm Co Ltd disclose the individual responsible for D&I?
Does TTY Biopharm Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does TTY Biopharm Co Ltd disclose current and / or historical scope 2 emissions?
Does TTY Biopharm Co Ltd disclose water use targets?
Does TTY Biopharm Co Ltd have careers partnerships with academic institutions?
Did TTY Biopharm Co Ltd have a product recall in the last two years?
Does TTY Biopharm Co Ltd disclose incidents of discrimination?
Does TTY Biopharm Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has TTY Biopharm Co Ltd issued a profit warning in the past 24 months?
Does TTY Biopharm Co Ltd disclose parental leave metrics?
Does TTY Biopharm Co Ltd disclose climate scenario or pathway analysis?
Does TTY Biopharm Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does TTY Biopharm Co Ltd disclose the pay ratio of women to men?
Does TTY Biopharm Co Ltd support suppliers with sustainability related research and development?
Does TTY Biopharm Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does TTY Biopharm Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is TTY Biopharm Co Ltd involved in embryonic stem cell research?
Does TTY Biopharm Co Ltd disclose GHG and Air Emissions intensity?
Does TTY Biopharm Co Ltd disclose its waste policy?
Does TTY Biopharm Co Ltd report according to TCFD requirements?
Does TTY Biopharm Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does TTY Biopharm Co Ltd disclose energy use targets?
Does TTY Biopharm Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does TTY Biopharm Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for TTY Biopharm Co Ltd
These potential risks are based on the size, segment and geographies of the company.
TTY Biopharm Company Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally. The company operates through Oncology Business Unit, Health Care Unit, Anti-infection Business Unit, Domestic Cardiovascular and Gastrointestinal Drugs Business Unit, China Medicine Business Unit, and Other segments. It offers oncology drugs under the Lipo-Dox, Lonsurf, UFUR, TS-1, Pexeda, Gemmis, Oxalip, Irino, Epicin, Tynen, Anazo, Folina, Thado, Andason, Ivic, Asadin, Leavdo, Painkyl, Megest, Episil, Otril, Zobonic, Yondelis, Veiasu, and Pemazyre names for anti-cancer and supplementary treatments. The company also provides anti-infection drugs under the Brosym, Colimycin, Cubicin, Lipo-AB, Agrippal, Cepiro, Flusine, Maxtam, Metacin, and Flucelvax names for anti-infection and flu. In addition, it offers healthcare related drugs under the Algitab, Alginos, Alginos Fresh, Bio-Cal Plus, and Sulfin names for digest system, osteoporosis, and metabolism. The company was founded in 1960 and is headquartered in Taipei, Taiwan.